Sign in

CIK 0001341235

  • Non-accelerated filer
  • Smaller reporting company

Aldeyra Therapeutics, Inc.

Sign in to watch
Ticker
ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-761-4904
Business address
23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
Former names
Aldexa Therapeutics, Inc., Neuron Systems Inc
Open-market buys, last 90 days
$140,275
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$140,275. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-09-06 Clark David J Chief Medical Officer Purchase +5,000 $5.06 $25K 17,878
2019-03-05 Clark David J Chief Medical Officer Grant or award +3,503 11,512
2019-03-05 Clark David J Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +250,000 250,000
2018-03-06 Clark David J Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +108,633 108,633
2017-12-29 Clark David J Chief Medical Officer Grant or award +4,774 $4.00 $19K 4,774
2017-03-03 Clark David J Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +155,656 155,656
2016-01-11 Clark David J Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +100,000 100,000

Page 1 of 1 · 7 trades